We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
-14.58%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
AUM
$1.9B
AUM Growth
-$862M
Cap. Flow
-$479M
Cap. Flow %
-25.16%
Top 10 Hldgs %
43.35%
Holding
99
New
27
Increased
22
Reduced
5
Closed
11

Top Sells

Rank Stock Value
1
ATRS
Antares Pharma, Inc.
ATRS
+$44.7M
2
NFE icon
New Fortress Energy
NFE
+$36.8M
3
CHGG icon
Chegg
CHGG
+$33.4M
4
AIR icon
AAR Corp
AIR
+$21.6M
5
GSM icon
FerroAtlántica
GSM
+$14M

Sector Composition

Rank Sector Weight
1 Healthcare 22.91%
2 Industrials 18.53%
3 Energy 12.47%
4 Financials 10.45%
5 Consumer Discretionary 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
76
Tvardi Therapeutics
TVRD
$22.2M
$2.44M 0.13%
+7,416
New +$2.6M
KORE
77
DELISTED
KORE Group Holdings
KORE
$2.19M 0.11%
142,450
SIOX
78
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2.17M 0.11%
6,011,005
+3,011,005
+100% +$1.25M
NAUT icon
79
Nautilus Biotechnolgy
NAUT
$114M
$2.01M 0.11%
747,607
PASG icon
80
Passage Bio
PASG
$15M
$1.94M 0.1%
+41,105
New +$1.92M
LYLT
81
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$1.78M 0.09%
498,504
QSI icon
82
Quantum-Si Incorporated
QSI
$187M
$1.56M 0.08%
672,385
MRNS
83
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.53M 0.08%
315,277
+71,803
+29% +$437K
LOTZ
84
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$1.18M 0.06%
3,000,000
RNAC icon
85
Cartesian Therapeutics
RNAC
$266M
$945K 0.05%
+24,042
New +$713K
SCTL
86
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$856K 0.05%
1,076,587
HOWL icon
87
Werewolf Therapeutics
HOWL
$18.8M
$838K 0.04%
+204,996
New +$935K
VIAO
88
DELISTED
VIA optronics AG American Depositary Shares, each representing one-fifth of an Ordinary Share
VIAO
$534K 0.03%
251,855
AGRO icon
89
Adecoagro
AGRO
$1.34B
-645,702
Closed -$7.8M
CHGG icon
90
Chegg
CHGG
$89.9M
-920,894
Closed -$33.4M
FROG icon
91
JFrog
FROG
$10.5B
-399,123
Closed -$10.8M
INVZ icon
92
Innoviz Technologies
INVZ
$114M
-2,062,757
Closed -$7.47M
IWM icon
93
PUT
iShares Russell 2000 ETF
IWM
$82.4B
-800,000
Closed -$164M
LAUR icon
94
Laureate Education
LAUR
$5.08B
-600,272
Closed -$7.11M
FLNA
95
Filana Therapeutics
FLNA
$45.5M
-69,401
Closed -$2.58M
SPY icon
96
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
-1,000,000
Closed -$452M
LUCK
97
Lucky Strike Entertainment
LUCK
$918M
-320,377
Closed -$3.41M
RETA
98
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
-138,556
Closed -$4.54M
ATRS
99
DELISTED
Antares Pharma, Inc.
ATRS
-10,900,000
Closed -$44.7M

Similar funds

Rubric Capital Management (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Rubric Capital Management (New York) held 99 positions worth $1.9B, down 31% from $2.77B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Rubric Capital Management (New York) withdrew a net $479M in Q2 2022, closing 11 positions and reducing 5 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $44.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 14% a quarter earlier, followed by Industrials and Energy.

Against the trend, Rubric Capital Management (New York) opened a new position in WillScot Mobile Mini Holdings worth $42.8M.

  • Rubric Capital Management (New York)'s largest Q2 2022 buy was WillScot Mobile Mini Holdings: 1,320,713 shares worth $42.8M.
  • Rubric Capital Management (New York) added most to Apollo Global Management in Q2 2022, an estimated $24.9M increase.
  • Rubric Capital Management (New York)'s biggest Q2 2022 reduction was New Fortress Energy, cutting an estimated $36.8M.
  • Rubric Capital Management (New York) fully exited Antares Pharma, Inc. in Q2 2022, selling an estimated $44.7M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 43% of its $1.9B portfolio in Q2 2022.
  • Rubric Capital Management (New York) opened 27 new positions and closed 11 in Q2 2022.
  • Rubric Capital Management (New York)'s portfolio value fell 31% quarter-over-quarter to $1.9B.

Based on Rubric Capital Management (New York)'s 13F filing for Q2 2022, filed 12 Aug 2022.